Draft for feedbackThese pages are still being checked.About this draft

Vaccine ingredients have a strong safety record

Vaccine ingredients have specific jobs, such as strengthening protection or keeping the vaccine stable. Safety depends on the amount, chemical form and how it enters the body. Studies support the safety of the amounts used. Serious reactions are rare.

  • Dose, chemical form and route matter when assessing an ingredient. [1][7]
  • The ingredient list is specific to each vaccine. [2][3]
  • Aluminum and thimerosal have not been shown to cause autism. [9]
See the sources ↓
On this page

Each ingredient has a job

Some ingredients train the immune response; others help it work, keep a vaccine stable or prevent contamination. Small manufacturing residues can remain. The M-M-R II label lists no aluminum, thimerosal or formaldehyde; VAXELIS has a different ingredient list. Manufacturing cell cultures are not interchangeable with final ingredients. Check the actual product label.

Aluminum helps some vaccines work

A 2026 review of 59 studies found no established broad serious long-term harm from aluminum adjuvants, while recognizing uncommon persistent itchy nodules and local hypersensitivity. Evidence quality varied, and rare or delayed outcomes remain less certain. A 2022 US study reported an asthma association; the later Danish cohort did not reproduce an increased asthma association. Association alone does not establish cause.

Small residues are assessed as injected doses

Some vaccines contain formaldehyde left over from manufacturing. Safety depends on the amount, route and how the body processes it. An infant model examining an injected dose found a small addition to the body’s existing formaldehyde burden. That supports the assessment; natural occurrence alone does not prove safety. This was a model, not a trial measuring every infant.

Thimerosal is formulation-specific

Thimerosal is a preservative that contains ethylmercury, which differs from methylmercury. Some multidose flu products have contained it; many vaccines do not. Studies do not support an autism link. An approved label, a recommendation and what is locally available are separate facts.

Safety and side effects

Uncommon aluminum-related nodules can cause prolonged discomfort. Severe allergic reactions to a vaccine component are rare but real. The ingredient, product and person’s history matter. Neither “natural” nor a chemical’s alarming name settles the safety of a particular exposure.

Vaccine ingredients have specific jobs, such as strengthening protection or keeping the vaccine stable.

Keep in mind

  • The findings apply to the vaccines, populations and outcomes studied. Personal recommendations depend on your health and current local guidance.

Sources you can check

  1. Common Ingredients in FDA-Approved Vaccines (opens in a new tab)

    FDA

    Ingredients serve different functions; safety assessment needs the product, amount and route of exposure.

    Return to reading ↑
  2. M-M-R II — Prescribing Information (opens in a new tab)

    FDA

    Ingredient and manufacturing information for this formulation, not every MMR product worldwide.

    Return to reading ↑
  3. VAXELIS — Prescribing Information (opens in a new tab)

    FDA

    Six-disease combination vaccine; ingredient amounts are product-specific.

    Return to reading ↑
  4. Aluminium adjuvants in vaccines and potential health effects: systematic review (opens in a new tab)

    BMJ, 2026

    59 studies with uneven evidence quality. Recognizes uncommon persistent local reactions and gaps for rare or delayed outcomes.

    Return to reading ↑
  5. Association Between Aluminum Exposure From Vaccines Before Age 24 Months and Persistent Asthma at Age 24 to 59 Months (opens in a new tab)

    Academic Pediatrics, 2022

    US observational association needing further study; residual confounding remains possible.

    Return to reading ↑
  6. Aluminum-Adsorbed Vaccines and Chronic Diseases in Childhood: A Nationwide Cohort Study (opens in a new tab)

    Annals of Internal Medicine, 2025

    Danish observational cohort of 1,224,176 children. Its supplement was corrected; rare-outcome uncertainty remains.

    Return to reading ↑
  7. Pharmacokinetic modeling as an approach to assessing the safety of residual formaldehyde in infant vaccines (opens in a new tab)

    Vaccine, 2013

    Models an intramuscular dose in a two-month-old infant; not direct measurement in every vaccinated child.

    Return to reading ↑
  8. Thimerosal and Vaccines (opens in a new tab)

    FDA

    Distinguishes ethylmercury from methylmercury; labels and recommendations need separate checks.

    Return to reading ↑
  9. Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) on vaccines and autism (opens in a new tab)

    WHO, 2025

    Assesses vaccine–autism evidence, including thimerosal and aluminum; this is not a finding of zero vaccine side effects.

    Return to reading ↑
Detailed research notes and source data

Our longer notes explain how we checked the studies, including disagreements and documents we could not get.

Download the detailed research notes →

Source data (JSON, for developers) →

Something unclear or missing?

You can save a feedback note to share with the site owner. The form saves a file on your device; it does not send it to us.

Save a feedback note →
About this draft

These pages have not completed expert review. For personal vaccine advice, talk to a clinician who knows your circumstances.

Research checked: . Wording reviewed: 2026-10-15. Version: vaccine-2026-10-15.

We revisit the page when new evidence or corrections change the answer. A public history of corrections is not available yet.

Related topics